Capturing the third dimension in drug discovery: Spatially-resolved tools for interrogation of complex 3D cell models

Biotechnol Adv. 2022 Mar-Apr:55:107883. doi: 10.1016/j.biotechadv.2021.107883. Epub 2021 Dec 4.

Abstract

Advanced three-dimensional (3D) cell models have proven to be capable of depicting architectural and microenvironmental features of several tissues. By providing data of higher physiological and pathophysiological relevance, 3D cell models have been contributing to a better understanding of human development, pathology onset and progression mechanisms, as well as for 3D cell-based assays for drug discovery. Nonetheless, the characterization and interrogation of these tissue-like structures pose major challenges on the conventional analytical methods, pushing the development of spatially-resolved technologies. Herein, we review recent advances and pioneering technologies suitable for the interrogation of multicellular 3D models, while capable of retaining biological spatial information. We focused on imaging technologies and omics tools, namely transcriptomics, proteomics and metabolomics. The advantages and shortcomings of these novel methodologies are discussed, alongside the opportunities to intertwine data from the different tools.

Keywords: 3D cell culture; Cell based-assays; Disease modeling; Imaging; MS-based tools; Spatially-resolved omics; Stem cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Discovery
  • Humans
  • Metabolomics*
  • Proteomics*
  • Transcriptome